Eli Lilly and Co. and its partner cannot stop competitors from selling generic versions of testosterone treatment Axiron, a federal judge in Indianapolis has ruled.
Named AZD3293, the drug belongs to a novel class of drugs that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Advocates want to see Indiana children from families earning up to at least 200 percent of the federal poverty line have access to high-quality pre-kindergarten programs.
(IBJ photo/Eric Learned) Bluelock Chief Technology Officer and Co-Founder Major company achievements during tenure: Bluelock focuses on disaster recovery—keeping businesses running even if a data center is destroyed or damaged. Bluelock’s work has earned the attention of IT analyst Gartner Inc., which named it a 2016 “Leader in the Disaster Recovery as a Service” category. […]
Eli Lilly and Co. CEO John Lechleiter and his wife, Sarah, have pledged $5 million to the United Way, an amount matched by the Eli Lilly and Co. Foundation.
Eli Lilly and Co. shares dipped Wednesday after a promising breast cancer treatment failed to meet interim efficacy criteria in a late-stage trial, possibly delaying its entry to market.
Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine.
Five years after pledging an astounding $48 million to help Marian University build a medical school, an Indianapolis businessman has paid only about one-fifth of that amount.
Dave Ricks will begin guiding the company during a period of relative calm compared with the trying times John Lechleiter navigated during his eight years at the helm.
Lilly tends to pull off these transitions with a minimum of drama, which is to its credit, thanks to its meticulous CEO succession planning and the board’s preference in recent decades for internal candidates who already know the Lilly way.
Over the last eight years, Eli Lilly relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now, it’ll rely on another long-time executive for its next chapter.
David Ricks fit the bill for the top job at Eli Lilly and Co. after 20 years with the firm in product development, sales and marketing, and public policy, according to outgoing CEO John Lechleiter.
John Lechleiter has been the company’s CEO since 2008. The announcement Wednesday morning of his retirement comes one day after the firm announced strong revenue and profit for its second quarter, indicating that Lechleiter’s initiatives have paid off.
CEO John Lechleiter said the company's strong R&D pipeline has put it on track to report average annual revenue growth of at least 5 percent through the remainder of the decade.
In picking Mike Pence as his running mate, Republican Donald Trump has added a seasoned fundraiser who could bring fresh energy and new donors to a finance operation lagging far behind that of his Democratic rival, Hillary Clinton.
Timothy Whicker started the Danville-based commercial electrical contractor above his garage a decade ago. Today, it has branch offices in Kokomo and Bloomington and 175 employees.
Former Mayor Greg Ballard might not have been as crazy as some people thought when he suggested Indianapolis could use cricket as a rallying point for businesses.
